Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.3)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download whole issue [PDF]

Contents – 2022, Vol. 31, No. 3 (March)

1

Editorial

Neurobiological advances of learned fear in humans

217-221

2

Original Article

Does a single dose of palonosetron have any role in preventing acute chemotherapy-induced nausea and vomiting in pediatric osteosarcoma patients without dexamethasone? A randomized clinical trial

223-230

3

Original Article

Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet’s uveitis

231-240

4

Original Article

Comparison of the radial and brachial artery flow-mediated dilation in patients with hypertension

241-248

5

Original Article

Serum WNT4 protein as an indicator of chronic glomerulonephritis but not a marker of inflammatory cell infiltration and fibrosis: A preliminary study

249-259

6

Original Article

Caprini VTE computerized risk assessment improves the use of thromboprophylaxis in hospitalized patients with pulmonary disorders

261-266

7

Original Article

A quasi-experimental study examining a nurse-led educational program to improve disease knowledge and self-care for patients with acute decompensated heart failure with reduced ejection fraction

267-275

8

Original Article

Melatonin protected against myocardial infarction injury in rats through a Sirt6-dependent antioxidant pathway

277-284

9

Original Article

Effects of ketamine, thiopental and their combination on the rat liver: A biochemical evaluation

285-292

10

Original Article

MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia

293-305

11

Original Article

Can monodisperse microbubble-based three-dimensional contrast-enhanced ultrasound reduce quantitative heterogeneity? An in vitro study

307-315

12

Review

Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment

317-326

13

Research Letter

Successful treatment of second-time CAR-T 19 therapy after failure of first-time CAR-T 19 and ibrutinib therapy in relapsed mantle cell lymphoma

327-335

14

Research Letter

Various clinical scenarios of primary melanoma of the esophagus: A retrospective 20-year analysis from two university thoracic surgery centers

337-344

15

Research Letter

Vedolizumab in highly resistant acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation: A single-center pediatric series

345-350